We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Appeals Court Reverses Ruling Against AbbVie and Co-defendants in AndroGel Case
Appeals Court Reverses Ruling Against AbbVie and Co-defendants in AndroGel Case
AbbVie, Abbott Laboratories, Unimed Pharmaceuticals and Besins Healthcare are off the hook for $448 million they would have had to pay to the Federal Trade Commission (FTC), thanks to a favorable ruling by a federal appeals court.